Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hourvash Ebrahimi-louyeh"'
Autor:
IRANDOKHT SHENAVAR MASOOLEH, ELHAM RAMEZANZADEH, MARYAM YASERI, SEYYEDE SAHERE MORTAZAVI KHATIBANI, HANIEH SADAT FAYAZI, HEYDAR ALI BALOU, HOURVASH EBRAHIMI LOUYEH, FATEMEH ZAERSABET, HOSSEIN KHOSHRANG, IDEH DADGARAN
Publikováno v:
Journal of Advances in Medical Education and Professionalism, Vol 9, Iss 3, Pp 168-175 (2021)
Introduction: There is no formal education or training course about daily progress note writing in Iranian medical interns’curriculum. The current study aimed to assess the effectiveness of a training intervention on daily progress note writing by
Externí odkaz:
https://doaj.org/article/c3fff2b0028e40609652d5dee0902674
Autor:
Seyyed Masoud Moafi Madani, Hourvash Ebrahimi Louyeh, Samaneh Ghazanfar Tehran, Hossein Khoshrang
Publikováno v:
Journal of Guilan University of Medical Sciences. 30:76-83
Hereditary spherocytosis (HS) is a familial hemolytic disorder with intracorpuscular mechanism that characterized by the production of red blood cells with sphere-like shape prone to hemolysis and can lead to hemolytic anemia, splenomegaly, jaundice
Publikováno v:
Rheumatology Research. 5:129-133
Since mid-December of 2019, an outbreak of pneumonia has been spread from Wuhan City, Hubei province, China, as a viralpneumonia. After virus identification and isolation, the pathogen for this pneumonia was originally called 2019 novelcoronavirus (2
Autor:
Elham Farhadi, Hossein Kazemzadeh, Tooba Ghazanfari, Ahmadreza Jamshidi, Maryam Edalatifard, Mahdi Mahmoudi, Seyed Reza Najafizadeh, Abdolrahman Rostamian, Saeidreza Jamalimoghadamsiahkali, Hourvash Ebrahimi Louyeh, Besharat Rahimi, Masoud Esfahani, Nasim Khajavirad, Maryam Akhtari, Nooshin Jalili, Mohammadreza Sattarian, Maedeh Mahmoodi Aliabadi, Zohre Naderi, Mohammadreza Salehi, Shayan Mostafaei, Seyed Reza Raeeskarami
Publikováno v:
The European Respiratory Journal
article-version (VoR) Version of Record
article-version (AM) Accepted Manuscript
article-version (VoR) Version of Record
article-version (AM) Accepted Manuscript
Introduction There are no determined treatment agents for severe COVID-19. It is suggested that methylprednisolone, as an immunosuppressive treatment, can reduce the inflammation of the respiratory system in COVID-19 patients. Methods We conducted a